Topiramate and word-finding difficulties in patients with epilepsy

Neurology

Volumn 60, Issue 7, 2003, Pages 1104-1107

  Mula, Marco ^a   Trimble, Michael R ^a   Thompson, Pamela ^a   Sander, Josemir W A S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TOPIRAMATE;

ADULT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; EVALUATION; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY; TITRIMETRY; WORD RECOGNITION;

EID: 0037426443     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000056637.37509.C6     Document Type: Article

References (18)

1. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, 600-mg dosages. Neurology 1996;46:1684-1690.
2. Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, 1000-mg dosages. Neurology 1996;46:1678-1683.
3. Tatum WO, French JA, Morris GL, et al. Postmarketing experience with topiramate and cognition. Epilepsia 2001;42:1134-1140.
4. Thompson PJ, Baxendale SA, Duncan JS, Sander JWAS. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000;69:636-641.
5. Commission on classification and terminology of the International League Against Epilepsy. Proposal for a revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
6. Biton V, Montouris GD, Ritter F. A study of topiramate in primary generalized tonic-clonic seizures. Neurology 1999;52:1330-1337.
7. Sachdeo RC, Glauser TA, Ritter RC, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999;52:1882-1887.
8. Elterman RD, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999;52:1338-1344.
9. Rorsman I, Kallen K. Recovery of cognitive and emotional functioning following withdrawal oftopiramate maintenance therapy. Seizure 2001;10:592-595.
10. Lhatoo SD, Wong ICK, Sander JTWAS. Prognostic factors affecting longterm retention of topiramate in patients with chronic epilepsy. Epilepsia 2000;41:338-341.
11. Aldenkamp AP, Baker G, Mulder OG, et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-1178.
12. Ojemann LM, Ojemann GA, Dodrill CB, Crawford CA, Holmes MD, Dudley DL. Language disturbances as side effects of topiramate and zonisamide therapy. Epilepsy Behav 2001;2:579-584.
13. Glick SD, Ross DA, Hough LB. Lateral asymmetry ofneurotransmitters in human brain. Brain Res 1982;234:53-63.
14. Hamberger MJ, Tamny TR. Auditory naming and temporal lobe epilepsy. Epilepsy Res 1999;35:229-243.
15. Mayeux R, Brandt J, Rosen J, Benson F. Interictal memory and language impairment in temporal lobe epilepsy. Neurology 1980;30:120-125.
16. Goodglas H, Wingfield A, Wayland SC. The nature of prolonged word search. Brain Lang 1989;36:411-419.
17. Gordon N. Cognitive functions and epileptic activity. Seizure 2000;9:184-188.
18. Bell B, Hermann B, Seindenberg M, et al. Ipsilateral reorganization of language in early-onset left temporal lobe epilepsy. Epilepsy Behav 2002;3:158-164.